Recall
FDAHealthJuly 30, 2025

GenoGenix LLC — NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33

⚠️ Lack of Assurance of Sterility

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 30, 2025

US Nationwide.

What's affected?

Product
NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health
Lot code
within

Additional details

All lots within expiry.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.